Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis
Sathish Babu Vasamsetti, Santosh Karnewar, Anantha Koteswararao Kanugula, et al.
Diabetes (2014) Vol. 64, Iss. 6, pp. 2028-2041
Open Access | Times Cited: 343

Showing 26-50 of 343 citing articles:

Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
Allison B. Goldfine, Steven E. Shoelson
Journal of Clinical Investigation (2017) Vol. 127, Iss. 1, pp. 83-93
Open Access | Times Cited: 147
Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management
Fei Luo, Avash Das, Jingfei Chen, et al.
Cardiovascular Diabetology (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 142
Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis
Qi Chen, Jianjun Lv, Wenwen Yang, et al.
Theranostics (2019) Vol. 9, Iss. 22, pp. 6424-6442
Open Access | Times Cited: 136
The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model
Alexandra Boussommier-Calleja, Y. Atiyas, Kristina Haase, et al.
Biomaterials (2018) Vol. 198, pp. 180-193
Open Access | Times Cited: 135
Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control
André Scheen, Nathalie Esser, Nicolas Paquot
Diabetes & Metabolism (2015) Vol. 41, Iss. 3, pp. 183-194
Closed Access | Times Cited: 134
Metformin treatment status and abdominal aortic aneurysm disease progression
Naoki Fujimura, Jiang Xiong, Ellen Kettler, et al.
Journal of Vascular Surgery (2016) Vol. 64, Iss. 1, pp. 46-54.e8
Open Access | Times Cited: 133
Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages
João Incio, Priya Suboj, Shan M. Chin, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0141392-e0141392
Open Access | Times Cited: 130
Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: Relevance in age-associated vascular dysfunction
Santosh Karnewar, Praveen Neeli, Devayani Panuganti, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 4, pp. 1115-1128
Open Access | Times Cited: 125
Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium
Ronald Goldberg, Vanita R. Aroda, David A. Bluemke, et al.
Circulation (2017) Vol. 136, Iss. 1, pp. 52-64
Open Access | Times Cited: 123
Mitochondrial Dysfunction in Atherosclerosis
Wenxi Peng, Guoding Cai, Yiping Xia, et al.
DNA and Cell Biology (2019) Vol. 38, Iss. 7, pp. 597-606
Closed Access | Times Cited: 123
Therapeutic potential of polyphenols in cardiovascular diseases: Regulation of mTOR signaling pathway
A. Sanches‐Silva, Lara Testai, Seyed Fazel Nabavi, et al.
Pharmacological Research (2020) Vol. 152, pp. 104626-104626
Closed Access | Times Cited: 115
Therapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of Diabetes
João S. Teodoro, Sara Nunes, Anabela P. Rolo, et al.
Frontiers in Physiology (2019) Vol. 9
Open Access | Times Cited: 114
Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation
Yoshitaka Kimura, Tamiko Yanagida, Akiko Onda, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2020) Vol. 40, Iss. 3, pp. 570-582
Open Access | Times Cited: 113
Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression
Zhong’e Zhou, Yong Tang, Xian Jin, et al.
Journal of Diabetes Research (2016) Vol. 2016, pp. 1-10
Open Access | Times Cited: 106
mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors
Tingting Wu, Yang Zhao, Hao Wang, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 105
Association between metformin prescription and growth rates of abdominal aortic aneurysms
Jonathan Golledge, Joseph V. Moxon, Jenna Pinchbeck, et al.
British journal of surgery (2017) Vol. 104, Iss. 11, pp. 1486-1493
Closed Access | Times Cited: 105
Mechanisms of Macrophage Polarization in Insulin Signaling and Sensitivity
Lucie Orliaguet, Élise Dalmas, Karima Drareni, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 103
Metformin: A Novel Weapon Against Inflammation
Bo Bai, Haibo Chen
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 97
NLRP3 (Nucleotide Oligomerization Domain–Like Receptor Family, Pyrin Domain Containing 3)–Caspase-1 Inflammasome Degrades Contractile Proteins
Darrell Wu, Pingping Ren, Yanqiu Zheng, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2017) Vol. 37, Iss. 4, pp. 694-706
Open Access | Times Cited: 95
Metformin, Macrophage Dysfunction and Atherosclerosis
Xiaojun Feng, Wenxu Chen, Xiayun Ni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 93
Colchicine Alleviates Cholesterol Crystal-Induced Endothelial Cell Pyroptosis through Activating AMPK/SIRT1 Pathway
Mengyue Yang, Hang Lv, Qi Liu, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-18
Open Access | Times Cited: 88
Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Demin Cheng, Qi Xu, Yue Wang, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 88
Long-term activation of the innate immune system in atherosclerosis
Anette Christ, Siroon Bekkering, Eicke Latz, et al.
Seminars in Immunology (2016) Vol. 28, Iss. 4, pp. 384-393
Open Access | Times Cited: 87
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?
Teresa Salvatore, Pia Clara Pafundi, Raffaele Galiero, et al.
Biomedicines (2020) Vol. 9, Iss. 1, pp. 3-3
Open Access | Times Cited: 87
Metformin as an anti-inflammatory agent: a short review
Robin Kristófi, Jan W. Eriksson
Journal of Endocrinology (2021) Vol. 251, Iss. 2, pp. R11-R22
Open Access | Times Cited: 81

Scroll to top